Shopping Cart 0
Cart Subtotal
AED 0

Novacyt SA (ALNOV) - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 8258

Details

Summary

Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt develops proprietary technology platform NOVAPREP, a next generation liquid based cytology solution focused on cancer management. The company's cytology solution is also used in medical laboratories for diagnoses of diseases based on the study of organs and tissues on a molecular level. It has operations in France and the UK. Novacyt is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Novacyt SA

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Novacyt SA Company Overview

Novacyt SA Company Snapshot

Novacyt SA Pipeline Products and Ongoing Clinical Trials Overview

Novacyt SA-Pipeline Analysis Overview

Novacyt SA-Key Facts

Novacyt SA-Major Products and Services

Novacyt SA Pipeline Products by Development Stage

Novacyt SA Pipeline Products Overview

Diagnostic Assay-Aspergillus

Diagnostic Assay-Aspergillus Product Overview

Diagnostic Assay-Pneumocystis

Diagnostic Assay-Pneumocystis Product Overview

Genesig-Cytomegalovirus Test

Genesig-Cytomegalovirus Test Product Overview

Genesig Kit-Human Papillomavirus 14

Genesig Kit-Human Papillomavirus 14 Product Overview

Genesig Kit-Zika Virus

Genesig Kit-Zika Virus Product Overview

Genesig q24

Genesig q24 Product Overview

Multiplex Test-Mosquito-Borne Diseases

Multiplex Test-Mosquito-Borne Diseases Product Overview

Next Generation NOVAPrep

Next Generation NOVAPrep Product Overview

Onconostica

Onconostica Product Overview

Single Nucleotide Polymorphism Assay

Single Nucleotide Polymorphism Assay Product Overview

Novacyt SA-Key Competitors

Novacyt SA-Key Employees

Novacyt SA-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Novacyt SA, Recent Developments

Jul 30, 2019: Novacyt announces Half-Year Trading Update

May 13, 2019: Novacyt announces launch of next-generation qPCR instrument

Apr 30, 2019: Novacyt full year 2018 results

Apr 08, 2019: Novacyt expands development partnership with Immunexpress

Feb 26, 2019: Novacyt: Funding update

Feb 12, 2019: Molecular diagnostic tests genesig Real-Time PCR BKV Kit (CE) and genesig Real-Time PCR EBV Kit (CE) to help transplantation and immunosuppressed patients

Jan 22, 2019: Novacyt revenues full year 2018

Dec 21, 2018: Novacyt launches two new CE-IVD marked molecular diagnostic kits

Dec 11, 2018: Novacyt announces update on strategic review of non-core assets

Dec 06, 2018: Completion of substantial q16 molecular diagnostics order expands clinical diagnostic reach in fast growing Chinese market

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Novacyt SA Pipeline Products by Equipment Type

Novacyt SA Pipeline Products by Development Stage


List Of Table

List of Tables

Novacyt SA Pipeline Products and Ongoing Clinical Trials Overview

Novacyt SA Pipeline Products by Equipment Type

Novacyt SA Pipeline Products by Indication

Novacyt SA, Key Facts

Novacyt SA, Major Products and Services

Novacyt SA Number of Pipeline Products by Development Stage

Novacyt SA Pipeline Products Summary by Development Stage

Diagnostic Assay-Aspergillus-Product Status

Diagnostic Assay-Aspergillus-Product Description

Diagnostic Assay-Pneumocystis-Product Status

Diagnostic Assay-Pneumocystis-Product Description

Genesig-Cytomegalovirus Test-Product Status

Genesig-Cytomegalovirus Test-Product Description

Genesig Kit-Human Papillomavirus 14-Product Status

Genesig Kit-Human Papillomavirus 14-Product Description

Genesig Kit-Zika Virus-Product Status

Genesig Kit-Zika Virus-Product Description

Genesig q24-Product Status

Genesig q24-Product Description

Multiplex Test-Mosquito-Borne Diseases-Product Status

Multiplex Test-Mosquito-Borne Diseases-Product Description

Next Generation NOVAPrep-Product Status

Next Generation NOVAPrep-Product Description

Onconostica-Product Status

Onconostica-Product Description

Single Nucleotide Polymorphism Assay-Product Status

Single Nucleotide Polymorphism Assay-Product Description

Novacyt SA, Key Employees

Novacyt SA, Subsidiaries

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Novacyt SA, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Medtech SA

Mauna Kea Technologies SAS

Eurobio Scientific SA

Anagenesis Biotechnologies SAS

AgCom biotech S.A.R.L.

Adebiotech

Acanthe Biotech

Company Profile

Company Profile Title

Summary

Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt develops proprietary technology platform NOVAPREP, a next generation liquid based cytology solution focused on cancer management. The company's cytology solution is also used in medical laboratories for diagnoses of diseases based on the study of organs and tissues on a molecular level. It has operations in France and the UK. Novacyt is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Novacyt SA

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Novacyt SA Company Overview

Novacyt SA Company Snapshot

Novacyt SA Pipeline Products and Ongoing Clinical Trials Overview

Novacyt SA-Pipeline Analysis Overview

Novacyt SA-Key Facts

Novacyt SA-Major Products and Services

Novacyt SA Pipeline Products by Development Stage

Novacyt SA Pipeline Products Overview

Diagnostic Assay-Aspergillus

Diagnostic Assay-Aspergillus Product Overview

Diagnostic Assay-Pneumocystis

Diagnostic Assay-Pneumocystis Product Overview

Genesig-Cytomegalovirus Test

Genesig-Cytomegalovirus Test Product Overview

Genesig Kit-Human Papillomavirus 14

Genesig Kit-Human Papillomavirus 14 Product Overview

Genesig Kit-Zika Virus

Genesig Kit-Zika Virus Product Overview

Genesig q24

Genesig q24 Product Overview

Multiplex Test-Mosquito-Borne Diseases

Multiplex Test-Mosquito-Borne Diseases Product Overview

Next Generation NOVAPrep

Next Generation NOVAPrep Product Overview

Onconostica

Onconostica Product Overview

Single Nucleotide Polymorphism Assay

Single Nucleotide Polymorphism Assay Product Overview

Novacyt SA-Key Competitors

Novacyt SA-Key Employees

Novacyt SA-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Novacyt SA, Recent Developments

Jul 30, 2019: Novacyt announces Half-Year Trading Update

May 13, 2019: Novacyt announces launch of next-generation qPCR instrument

Apr 30, 2019: Novacyt full year 2018 results

Apr 08, 2019: Novacyt expands development partnership with Immunexpress

Feb 26, 2019: Novacyt: Funding update

Feb 12, 2019: Molecular diagnostic tests genesig Real-Time PCR BKV Kit (CE) and genesig Real-Time PCR EBV Kit (CE) to help transplantation and immunosuppressed patients

Jan 22, 2019: Novacyt revenues full year 2018

Dec 21, 2018: Novacyt launches two new CE-IVD marked molecular diagnostic kits

Dec 11, 2018: Novacyt announces update on strategic review of non-core assets

Dec 06, 2018: Completion of substantial q16 molecular diagnostics order expands clinical diagnostic reach in fast growing Chinese market

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Novacyt SA Pipeline Products by Equipment Type

Novacyt SA Pipeline Products by Development Stage


List Of Table

List of Tables

Novacyt SA Pipeline Products and Ongoing Clinical Trials Overview

Novacyt SA Pipeline Products by Equipment Type

Novacyt SA Pipeline Products by Indication

Novacyt SA, Key Facts

Novacyt SA, Major Products and Services

Novacyt SA Number of Pipeline Products by Development Stage

Novacyt SA Pipeline Products Summary by Development Stage

Diagnostic Assay-Aspergillus-Product Status

Diagnostic Assay-Aspergillus-Product Description

Diagnostic Assay-Pneumocystis-Product Status

Diagnostic Assay-Pneumocystis-Product Description

Genesig-Cytomegalovirus Test-Product Status

Genesig-Cytomegalovirus Test-Product Description

Genesig Kit-Human Papillomavirus 14-Product Status

Genesig Kit-Human Papillomavirus 14-Product Description

Genesig Kit-Zika Virus-Product Status

Genesig Kit-Zika Virus-Product Description

Genesig q24-Product Status

Genesig q24-Product Description

Multiplex Test-Mosquito-Borne Diseases-Product Status

Multiplex Test-Mosquito-Borne Diseases-Product Description

Next Generation NOVAPrep-Product Status

Next Generation NOVAPrep-Product Description

Onconostica-Product Status

Onconostica-Product Description

Single Nucleotide Polymorphism Assay-Product Status

Single Nucleotide Polymorphism Assay-Product Description

Novacyt SA, Key Employees

Novacyt SA, Subsidiaries

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Novacyt SA, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Medtech SA

Mauna Kea Technologies SAS

Eurobio Scientific SA

Anagenesis Biotechnologies SAS

AgCom biotech S.A.R.L.

Adebiotech

Acanthe Biotech